ESR1 and breast carcinoma: Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer, characterized by the absence of expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).